disclosure

California Public Pension Crisis: The Ticking Time Bomb, a Full Disclosure Network Cable TV Series

In a bombshell exposé of California's massive, unfunded public employee retirement benefits, Full Disclosure Network® is re-releasing a two-part series on 40 cable systems featuring public pension fund officials and finance experts, including Mr. B. Scott Minerd, CEO Guggenheim Partner...

Panel Seeks Fuller Disclosure of Drug Company Payments

Government report also suggests gift ban, drug sample limits TUESDAY, April 28 (HealthDay News) -- A government panel is calling on Congress to require drug, device and biotechnology companies to publicly report payments they make to certain individuals and institutions, including phys...

ULURU Inc. ('ULURU') Dealing Disclosure Requirements

ADDISON, Texas, April 6 /PRNewswire-FirstCall/ -- ULURU Inc. (NYSE Amex: ULU ) the following is an announcement that ULURU has been requested to publish by the Takeover Panel in the United Kingdom. They have requested this announcement because, whether there has been an offer or not, the Form...

Privacy Watchdog Condemns Google for Effort to Defund it: Calls for Greater Corporate Disclosure About Lobbying Efforts and Independent Privacy Chief

WASHINGTON, Feb. 23 /PRNewswire-USNewswire/ -- Consumer Watchdog President Jamie Court wrote Google's CEO Eric Schmidt today questioning the company's priorities following efforts by one of Google's top executives to dissuade a charitable foundation from supporting the nonpartisan group's privacy ...

DIA Conference to Present Latest Strategies in Clinical Trial Disclosure Compliance

Experts from government, the pharmaceutical and biotech industries, and medical device companies will discuss best practices to ensure compliance with clinical trial disclosure laws and regulations, the Clinical Trials.gov registry, and results database during the Drug Information Association's (...

NJHA: Public Deserves Full Disclosure of Horizon Conversion Plan

PRINCETON, N.J., Sept. 11 /PRNewswire-USNewswire/ -- The New Jersey Hospital Association today called for greater transparency of Horizon Blue Cross/Blue Shield's application to become a for-profit company. "There is far too much at stake for the people of New Jersey to have this process pro...

Vioxx Disclosure Emphasizes Need for New Web Resource that Answers Questions About Anti-Epileptic Medication Use

Prescribing for Better Outcomes Offers Unbiased, Comprehensive Analysis of Drug Research; Site Comes in Response to 2004 Pharmaceutical Suit Against Warner-Lambert CHAPEL HILL, N.C., April 17 /PRNewswire-USNewswire/ --- Physicians and consumers who want fair and balanced information about ...

URAC Announces Support for Principles of Disclosure Project's Patient Charter

Accreditation organization revising standards to include review of physician quality measurement programs to enhance transparency WASHINGTON, April 1, 2008 /PRNewswire-USNewswire/ -- URAC, one of the nation's leading independent accrediting organizations, announced today its support for th...

AdvaMed Supports Key Changes to Disclosure Legislation

Key Changes Recommended to S. 2029 to Ensure Information is Meaningful and in Appropriate Context WASHINGTON, Feb. 26 /PRNewswire-USNewswire/ -- The Advanced Medical Technology Association (AdvaMed) today expressed support for the appropriate disclosure of financial relationships with phys...

Federal toxics disclosure law could help inform public of nanotechnology risks

The Project on Emerging Nanotechnologies (PEN) is releasing a first-time legal analysis that finds a key federal toxics reporting statute could be applied to production and commercialization of nanotechnology, providing the public with more information about these revolutionary -- yet still potent...

disclosure in Medical Technology

Clinical Trial Participation Unaffected by Disclosure of Investigator's Financial Stake, Food and Drug Law Journal Article Finds

WASHINGTON, Dec. 18 /PRNewswire-USNewswire/ -- The willingness to participate in a clinical investigation of a new drug or device is not affected by the investigator's financial stake in the outcome of the trial, concludes a new study reported in an article in the latest issue of the Food and ...

FDA Advisory Committee Votes in Favor of SAPHRIS(R) (asenapine) for Acute Bipolar I Disorder and Acute Schizophrenia

...y its colleagues around the world. The company is based in Kenilworth, N.J., and its Web site is www.schering-plough.com . SCHERING-PLOUGH disclosure NOTICE: The information in this press release includes certain "forward-looking statements" within the meaning of the Private Securities Litigation R...

Schering-Plough Announces U.S. Filing of Mometasone Furoate/Formoterol Fumarate Combination for the Maintenance Treatment of Asthma

...v/medwatch , or call 1-800-FDA-1088. Please see additional important product information for FORADIL AEROLIZER. SCHERING-PLOUGH disclosure NOTICE: The information in this press release includes certain "forward-looking statements" within the meaning of the Private Securities Litigation R...

Schering-Plough Expands Vicriviroc Phase II Study in Treatment-Naive Patients With HIV

...olleagues around the world. The company is based in Kenilworth, N.J., and its Web site is www.schering-plough.com . SCHERING-PLOUGH disclosure NOTICE: The information in this press release includes certain "forward-looking statements" within the meaning of the Private Securities Litigation R...

ASMANEX(R) (Mometasone Furoate Dry Powder Inhaler) Now Approved in Japan for the Treatment of Bronchial Asthma in Adult Patients

... by its colleagues around the world. The company is based in Kenilworth, N.J., and its Web site is www.schering-plough.com . SCHERING-PLOUGH disclosure NOTICE: The information in this press release includes certain "forward-looking statements" within the meaning of the Private Securities Litigation R...

SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis

... by its colleagues around the world. The company is based in Kenilworth, N.J., and its Web site is www.schering-plough.com . SCHERING-PLOUGH disclosure NOTICE: The information in this press release includes certain "forward-looking statements" within the meaning of the Private Securities Litigation Re...

New Analysis Shows Efficacy of SIMPONI(TM) (golimumab) in Anti-TNF Experienced Rheumatoid Arthritis Patients

...ed by its colleagues around the world. The company is based in Kenilworth, N.J., and its Web site is www.schering-plough.com . SCHERING-PLOUGH disclosure NOTICE: The information in this press release includes certain "forward-looking statements" within the meaning of the Private Securities Litigation Re...

Two-Year Data Show Patients Receiving SIMPONI(TM) (golimumab) Experienced Sustained Improvement in Signs and Symptoms of Psoriatic Arthritis and Ankylosing Spondylitis

...ed by its colleagues around the world. The company is based in Kenilworth, N.J., and its Web site is www.schering-plough.com . SCHERING-PLOUGH disclosure NOTICE: The information in this press release includes certain "forward-looking statements" within the meaning of the Private Securities Litigation Re...

PharmAthene Submits Proposal to BARDA in Response to Broad Agency Announcement for Advanced Research and Development for Valortim(R)

... that Valortim(R) will be shown to be safe and effective and approved by regulatory authorities for use in humans. Copies of PharmAthene's public disclosure filings are available from its investor relations department and our website under the investor relations tab at www.pharmathene.com . ...

Medarex Announces Allowance of Investigational New Drug Application for Wholly-Owned Fully Human Anti-CXCR4 Antibody, MDX-1338

...f MDX-1338, as well as risks detailed from time to time in Medarex's public disclosure filings with the U.S. Securities and Exchange Commission (SEC), including i...cts would ultimately achieve commercial success. Copies of Medarex's public disclosure filings are available from its investor relations department. Medarex...

disclosure in Medical Products

IQmark Digital Recorder^CF

Description:... 24-hour full disclosure Input range: 5mV Analog bandwidth: 0.05 to 100Hz (3dB) Common mode rejection ratio: 60dB Dimensions: 4.46in. x 2.75in. x 1.02in. (113m...
Company:Midmark Diagnostics Group

Escort Vision

Description:...tion of central monitoring and clinical information system (CIS) features. With auto-admission all central monitoring features, including alarms, full disclosure and vital sign charting, begin upon connecting your patient to a bedside monitor or telemetry transmitter....
Company:Invivo Corporation

Panorama™ Central Station

Description:... The Panorama Central Station includes bi-directional communication with Datascope bedside monitors, optional 72 hours of disclosure and a touch screen user interface....
Company:Datascope Corp.

eCHARMS

Description:...comprises the Web-based applications in the CHARMS 2000 product line. Currently, there are modules for imaging, electronic signature & enterprise-wide disclosure reporting. In addition, theres a unique new HIM management tool. These products can run over the Internet or on your institutions intranet....
Company:Meta Health Technology, Inc.

S/5 iCentral

Description:... and numerics, and up to 72 hours of trend, event history with snapshots and full-disclosure information for all parameters. With up to 23 stored full disclosure waveforms per patient and other historical information you can get a good understanding of the development of patient condition over the last few days...
Company:Datex-Ohmeda, Inc.

S/5 Arrhythmia Workstation

Description:... 999 arrhytmia events per patient can be stored and reviewed. Optional full disclosure provides 24-hour storage of ECG with two channels. Event summaries facilitates fast reviewing, either event by event or in full disclosure view. Color-coded alarms are configurable for individual needs. The 72 h...
Company:Datex-Ohmeda, Inc.

NCP-2 External Counterpulsation Device

Description:... With the launch of the NCP-2, ACS proudly introduces full disclosure to ECP Therapy. ACS has given physicians more tools for assessing the administration of ECP therapy through the first and only complete ECP Treatment ...
Company:Applied Cardiac Systems, Inc

Infinity MultiView WorkStation

Description:... MULTIVIEW WORKSTATION has built-in Event and Full disclosure capabilities, reducing the need to purchase separa...line calipers to measure intervals. Full and Event disclosure data can be retained temporarily for retrospective...e patient has been discharged. Both Full and Event disclosure provide a wide variety of chart-ready reports to a...
Company:Drger Medical

X-Scribe II Stress Exercise System

Description:...user profiles and the improved editing capabilities Windows provides to make the entire testing and reporting process more efficient. One-hundred full disclosure patient studies may be stored in internal memory, and the X-Scribe II allows the user to print using a high-speed laser printer to significantly reduc...
Company:Mortara Instrument, Inc.

ECT WS2000

Description:...lastly, it manages a high performance thermal printer for real time or full disclosure printouts (full disclosure for one or more leads, tables, arrhythmias, measurements, averaging, graphs...
Company:CARDIOLINE

disclosure in Medical Definition

Medicine

... References ^ AHIMA e-HIM Work Group on the Legal Health Record. (2005). " Update: Guidelines for Defining the Legal Health Record for disclosure Purposes. ". Journal of AHIMA 78 (8): 64A–G. ^ Coulehan JL, Block MR (2005). The Medical Interview: Mastering Skills for Clinical Prac...

disclosure in Biological News

Carbon Disclosure Project: 'World's largest corporations seek clarity on climate change regulation'

Global corporations view climate change as a driver of risk and opportunity and have cited clear regulation as key to managing the impacts, in this year's findings from the Carbon Disclosure Project (CDP), which includes exclusive data from 1550 of the world's major companies on greenhouse gas emi...

Carbon Disclosure Project, ICLEI partner to help US cities report local climate actions, emissions

The Carbon Disclosure Project (CDP) and ICLEI-Local Governments for Sustainability are joining forces with some of the United States' largest cities to help them voluntarily report their greenhouse gas emissions and other climate change-relevant data. This project marks a significant step in ...

World's largest investor coalition seeks further disclosure on climate change and shareholder value

The Carbon Disclosure Project (CDP) a collaboration of 385 institutional investors, with assets under management of $57 trillion, has issued its 2008 information request to the worlds largest corporations. This asks companies to measure and disclose their greenhouse gas emissions and report on the...

Report shows the power of US cities to mitigate climate change and steps they need to take to adapt

... from the residents and businesses in their communities, according to a new report. The report summarizes findings of a joint project by the Carbon disclosure Project (CDP) and ICLEI- Local Governments for Sustainability USA (ICLEI), launched in 2008 to encourage cities to voluntarily disclose greenhouse gas...

Oscar Pistorius: Previously confidential study results released on amputee sprinter

...esults because our study includes critical new data not presented in the CAS eligibility hearing. In addition to informing an interested public, full disclosure is in the best interests of Oscar Pistorius, other track athletes and the sport of Track and Field. The controversy raised by Oscar's inspiring perfo...

Gutsy germs succumb to baby broccoli

...t the levels of infection and inflammation were reduced suggests the likelihood of getting gastritis and ulcers and cancer is probably reduced." In disclosure of a potential conflict of interest, Fahey is a cofounder of, but holds no equity in, a company that is licensed by The Johns Hopkins University to pr...

Children born after donor insemination should be told as soon as possible about their conception

...m a bit more curious." Dr Jadva concluded: "This study shows that age of disclosure is important in determining donor offspring's feeling about their conceptio...ith research on adoption, which also shows that children benefit from early disclosure about the circumstances of their birth. "In light of the trend toward g...

NASA scientist James Hansen to speak at July 11 conference on 'Rejuvenating Public Sector Science'

...fectiveness Agenda The Energy Future: Whose Alternatives? Conservation in a Hostile Climate A Common Standard for Journals' Conflict of Interest disclosure Additional Speakers will include: Representative Brad Miller, Chairman, Subcommittee on Investigations and Oversight, House Committee on Science a...

Need for federal protection against genetic discrimination

...rs not to misuse their genetic information through disclosure or discriminatory practices- should they have acce...n and informed consent should be required for each disclosure of genetic information and should include to whom the disclosure is made. Finally, ACP considered specific Congr...

Markets of biodiversity and equity in trade: An illusion?

...ny different notions: filing of patents on applications or properties of plants collected in local communitieswith or without consent, disclosure or use of traditional knowledge for commercial ends, filing of common names as trade names, agreements whose clauses or implementation are unsatisfact...

disclosure in Biological Technology

Inverness Medical Innovations - Concateno plc, Further Announcement Regarding UK Takeover Code Share Dealing Disclosure Requirements.

WALTHAM, Mass., June 30 /PRNewswire-FirstCall/ -- In connection with its proposed acquisition of London based, drugs of abuse testing company Concateno plc, announced on June 5 2009, Inverness Medical Innovations, Inc. (NYSE: IMA ) has been requested by the UK Takeover Panel to remind Inverness ...

Schering-Plough Shareholders Approve Merger With Merck

... per common share (subject to declaration by the board of directors and a variety of factors including business and financial considerations). disclosure NOTICE: The information in this press release and other written reports and oral statements made from time to time by the company may contain "forw...

Kensey Nash Announces Agreement to Acquire Rights to OsseoFit Product

...es. For a detailed discussion of factors that could affect the Company's future operating results, please see the Company's SEC filings, including the disclosure under "Risk Factors" in those filings. Except as expressly required by the federal securities laws, the Company undertakes no obligation to update or ...

ADVENTRX Pharmaceuticals Announces Financing

...ho do not have substantial previous experience in executive leadership roles will negatively impact its ability to raise capital or maintain effective disclosure controls and procedures or internal control over financial reporting; the risk that ADVENTRX's common stock will be delisted by the NYSE Amex, includi...

PharmAthene, Inc. Closes on $19.3 Million Private Placement of Convertible Notes and Common Stock Warrants

...rded to the Company, merger & acquisition or corporate partnering activities, or unexpected financial obligations. Copies of PharmAthene's public disclosure filings are available from its investor relations department and our website under the investor relations tab at www.PharmAthene.com. ...

CuraGen Reports Second Quarter 2009 Financial Results

...e lawsuits far outweighed the benefits of continued litigation. Therefore, we have agreed to the terms of a settlement, which will include additional disclosure in the final proxy statement regarding the merger and, if approved by the court, a payment for the shareholder plaintiffs' attorneys' fees and expense...

Mylan Reports Adjusted Diluted EPS of $0.32 for the Quarter Ended June 30, 2009

...at an evaluation of its ongoing operations (and comparisons of its current operations with historical and future operations) would be difficult if the disclosure of its financial results were limited to financial measures prepared only in accordance with accounting principles generally accepted in the U.S. (GAA...

NeoGenomics Reports Second Quarter 2009 Results

... ======== ======== SUPPLEMENTAL disclosure OF CASH FLOW INFORMATION: Interest paid ... == == SUPPLEMENTAL disclosure OF NON-CASH INVESTING AND FINANCING ACTIVITIES: Equipment ...

SAPHRIS(R) (asenapine) Meets Primary Endpoint in Long-Term Extension Study in Patients With Predominant, Persistent Negative Symptoms of Schizophrenia

... by its colleagues around the world. The company is based in Kenilworth, N.J., and its Web site is www.schering-plough.com. SCHERING-PLOUGH disclosure NOTICE: The information in this press release includes certain "forward-looking statements" within the meaning of the Private Securities Litigation R...

Schering-Plough Reports Financial Results for 2009 Second Quarter

... and clicking on the "Presentations/Webcasts" link. A replay of the webcast will be available starting on July 21 through 5 p.m. on Aug. 21. disclosure NOTICE: The information in this press release, the comments of Schering-Plough officers during the earnings teleconference/webcast on July 21...

disclosure in Biological Dictionary

Hydrolytic enzyme

...rough its hydrolytic release of an immobilized indicator enzyme ... US4197291: Hydrolytic enzyme material. Country: US United States of ... disclosure relates to novel hydrolytic enzyme product derived from the pineapple ... Model of cellulase enzyme , produced by T. fusca, based on PDB struc...